Correlation Between C4 Therapeutics and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Keros Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Keros Therapeutics.
Diversification Opportunities for C4 Therapeutics and Keros Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between CCCC and Keros is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Keros Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Keros Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Keros Therapeutics. In addition to that, C4 Therapeutics is 1.79 times more volatile than Keros Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Keros Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 5,964 in Keros Therapeutics on August 31, 2024 and sell it today you would lose (109.00) from holding Keros Therapeutics or give up 1.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Keros Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Keros Therapeutics |
C4 Therapeutics and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Keros Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |